New Zealand · Seed startup

Who invested in Amaroq Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$9.7Mraised across 1 round since 2021, from 1 source

Latest round
Seed, $9.7MJul 2021
Investors
1
See who backed them

The rounds

  1. Jul 2021
    Seed$9.7M

    Source recorded

Founders and team

From Amaroq Therapeutics's own website: 1 founder, 3 on the team.

Dr Sarah HerridgeFounder
  • Dr Rachael BrakeCEO
  • Dr Phil KearneyChair of the Board
  • Dr Sarah MeidingerOperations Manager

AdvisersProf Jacob George

Everyone who backed them

Brandon CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Amaroq Therapeutics

Who invested in Amaroq Therapeutics?

Amaroq Therapeutics's investors include Brandon Capital.

How much has Amaroq Therapeutics raised?

Amaroq Therapeutics has raised $9.7M across 1 round since 2021.

When did Amaroq Therapeutics last raise?

Amaroq Therapeutics's most recent round was a Seed of $9.7M in Jul 2021.

What was Amaroq Therapeutics's biggest round?

Its most recent round, $9.7M in Jul 2021, is also its largest on record.

Who backed Amaroq Therapeutics first?

Amaroq Therapeutics's first round on record, in Jul 2021, was backed by Brandon Capital.

What stage is Amaroq Therapeutics at?

Amaroq Therapeutics's latest named round is a Seed, in Jul 2021.

Where is Amaroq Therapeutics based?

Amaroq Therapeutics is based in New Zealand.

Companies like Amaroq Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.